Lonza and the next wave of healthcare solutions

May 5, 2026

Temps de lecture: 3:57 mins

Walter Scott’s John Rae assesses outsourced drugs manufacturer Lonza’s role in the healthcare ecosystem.

Key points:

Lonza’s role in the healthcare space is simliar to that of chip manufacturers in the semiconductor supply chain.
The company has high customer retention which creates resilient revenues.
It is investing heavily to support growth, including building manufacturing capacity in the US.
Walter Scott sees several quality healthcare businesses with high degrees of profitability, cash generation and low levels of debt.

3305309 Exp: 7 août 2026

Rapports | Macroéconomique

Monthly Checkpoints

Checkpoints is a comprehensive monthly chartbook highlighting major top-of-mind themes that could shape financial markets in the near term. In addition to the broader macroeconomic discussion, Checkpoints delivers detailed views on major asset classes, including global equities, fixed income and real assets.

Chart of the Week | Macroéconomique

Resilient through uncertainty

U.S. policy uncertainty has remained elevated and consumer sentiment has weakened. Even so, the economy has stayed resilient, and because growth has held up better than sentiment and headlines suggest, we continue to forecast 2% U.S. growth in 2026, in line with trend.

Articles | Macroéconomique

Fiscal dominance, inflation and the future of portfolio construction

The rules of the market may have changed. How should multi-asset investors respond?

IFMH | Gestion Actions

Where’s the long-term value in AI?

AI investment enthusiasm is rising, but returns will vary widely. Long-term value is more likely where practical, commercially viable use cases are already beginning to emerge, says Walter Scott’s George Dent.